Australia markets closed
  • ALL ORDS

    7,713.10
    -32.80 (-0.42%)
     
  • AUD/USD

    0.6940
    +0.0050 (+0.72%)
     
  • ASX 200

    7,504.10
    -34.90 (-0.46%)
     
  • OIL

    75.15
    +1.04 (+1.40%)
     
  • GOLD

    1,886.30
    +6.80 (+0.36%)
     
  • BTC-AUD

    33,046.41
    +22.82 (+0.07%)
     
  • CMC Crypto 200

    526.53
    +1.40 (+0.27%)
     

Is Doximity's Stock Still Too Expensive to Buy?

Is Doximity's Stock Still Too Expensive to Buy?

Ever since Doximity (NYSE: DOCS) went public in June 2021, the stock has been commanding a significant premium. Unsurprisingly, as investors have become more focused on valuations and earnings multiples, shares of Doximity have been falling in value and are down 38% year to date. Investors may be wondering if this has created a buying opportunity for a business that still sees plenty of growth in its future.